Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Albertsons Companies (ACI) Cash & Equivalents (2017 - 2026)

Albertsons Companies filings provide 10 years of Cash & Equivalents readings, the most recent being $198.6 million for Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents fell 32.36% year-over-year to $198.6 million, compared with a TTM value of $198.6 million through Feb 2026, down 32.36%, and an annual FY2026 reading of $198.6 million, down 32.36% over the prior year.
  • Cash & Equivalents hit $198.6 million in Q1 2026 for Albertsons Companies, up from $195.1 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $4.4 billion in Q4 2022, with the low at $151.0 million in Q2 2025.
  • Median Cash & Equivalents over the past 5 years was $270.6 million (2025), compared with a mean of $1.0 billion.
  • The sharpest move saw Cash & Equivalents skyrocketed 69.02% in 2022, then tumbled 94.95% in 2023.
  • Year by year, Cash & Equivalents stood at $4.4 billion in 2022, then plummeted by 94.95% to $222.7 million in 2023, then decreased by 9.16% to $202.3 million in 2024, then decreased by 3.56% to $195.1 million in 2025, then increased by 1.79% to $198.6 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $198.6 million, $195.1 million, and $270.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.